• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.

作者信息

Mendel Arielle, Bernatsky Sasha, Askanase Anca, Bae Sang-Cheol, Clarke Ann Elaine, Costedoat-Chalumeau Nathalie, Gladman Dafna D, Gordon Caroline, Hanly John, Jacobsen Søren, Kalunian Ken, Mak Anselm, Mosca Marta, Pons-Estel Bernardo A, Ruiz-Irastorza Guillermo, Urowitz Murray, Vinet Évelyne

机构信息

Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada

Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.

出版信息

Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.

DOI:
10.1136/annrheumdis-2020-218164
PMID:32586918
Abstract
摘要

相似文献

1
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.2019年冠状病毒病大流行期间系统性红斑狼疮患者的羟氯喹短缺情况：系统性红斑狼疮国际协作诊所的经验
Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.
2
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety.羟氯喹在 COVID-19 危机期间的供应情况及其对患者焦虑的影响。
Lupus Sci Med. 2021 Apr;8(1). doi: 10.1136/lupus-2021-000496.
3
Hydroxychloroquine shortages during the COVID-19 pandemic.2019冠状病毒病大流行期间羟氯喹的短缺情况。
Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20.
4
Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand.新西兰在2019年冠状病毒病疫情期间采取的监管行动，以保护批准的风湿性适应症患者获得羟氯喹的机会。
Arthritis Rheumatol. 2021 May;73(5):896-897. doi: 10.1002/art.41643. Epub 2021 Mar 7.
5
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.氯喹和羟氯喹治疗新冠病毒疾病的潜力引发了系统性红斑狼疮患者对药物短缺的担忧。
Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.
6
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生重症新型冠状病毒肺炎。
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
7
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.
8
Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian ' by Notz .回复：“抗风湿药物、B细胞耗竭与重症COVID-19：关于Mathian等人‘17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程’的通信” 作者：诺茨
Ann Rheum Dis. 2022 Nov;81(11):e217. doi: 10.1136/annrheumdis-2020-218795. Epub 2020 Nov 25.
9
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian .
Ann Rheum Dis. 2022 Nov;81(11):e216. doi: 10.1136/annrheumdis-2020-218778. Epub 2020 Aug 28.
10
COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus.一名接受司库奇尤单抗治疗、患有化脓性汗腺炎和系统性红斑狼疮的患者感染了新冠病毒。
Int J Dermatol. 2020 Nov;59(11):1423-1424. doi: 10.1111/ijd.15209. Epub 2020 Sep 23.

引用本文的文献

1
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.伊维菌素、氯喹/羟氯喹及阿奇霉素治疗新冠肺炎的疗效：III期临床试验的系统评价
Biomedicines. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206.
2
What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation: The Rheumatology Experience.SARS-CoV-2 大流行让我们了解到免疫抑制、疫苗接种和免疫失调：风湿病学的经验。
Curr Allergy Asthma Rep. 2024 Apr;24(4):221-232. doi: 10.1007/s11882-024-01139-9. Epub 2024 Apr 3.
3
The Fragility of Scientific Rigour and Integrity in "Sped up Science": Research Misconduct, Bias, and Hype and in the COVID-19 Pandemic.
“加速科学”中科学严谨性与诚信的脆弱性：研究不当行为、偏见、炒作与新冠疫情
J Bioeth Inq. 2023 Dec;20(4):607-616. doi: 10.1007/s11673-023-10289-w. Epub 2023 Dec 8.
4
Comment: Is off-label medication use in the ICU a problem?评论：在重症监护病房（ICU）使用未标明适应证的药物是个问题吗？
Crit Care. 2023 Jul 15;27(1):288. doi: 10.1186/s13054-023-04546-y.
5
Meet the Medicines-A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines Online.Meet the Medicines—一种通过众包方式在线收集和传播基本药物信息的方法。
Int J Environ Res Public Health. 2023 Feb 27;20(5):4242. doi: 10.3390/ijerph20054242.
6
The Lancet Commission on lessons for the future from the COVID-19 pandemic.《柳叶刀》新冠疫情对未来的启示委员会
Lancet. 2022 Oct 8;400(10359):1224-1280. doi: 10.1016/S0140-6736(22)01585-9. Epub 2022 Sep 14.
7
COVID-19 in patients with systemic lupus erythematosus: A systematic review.COVID-19 与系统性红斑狼疮：系统综述。
Lupus. 2022 May;31(6):684-696. doi: 10.1177/09612033221093502. Epub 2022 Apr 5.
8
[Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].[羟氯喹：皮肤科的一种基本药物及其在 COVID-19 中的争议性应用]
Actas Dermosifiliogr. 2022 Feb;113(2):166-175. doi: 10.1016/j.ad.2021.07.005. Epub 2021 Aug 2.
9
Drug Policies Skyline during COVID-19 Pandemic.新冠疫情期间的毒品政策概况
J Clin Med. 2021 Jul 15;10(14):3117. doi: 10.3390/jcm10143117.
10
Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort.COVID-19 大流行第一波对系统性红斑狼疮患者的影响：一项多中心前瞻性队列研究的结果。
Lupus. 2021 Oct;30(11):1747-1755. doi: 10.1177/09612033211033981. Epub 2021 Jul 20.